Prospects and Potential for Chimerism Analysis after Allogeneic Hematopoietic Stem Cell Transplantation
Chimerism analysis after allogeneic hematopoietic stem cell transplantation serves to
confirm engraftment, indicate relapse of hematologic malignancy, and attribute graft failure …
confirm engraftment, indicate relapse of hematologic malignancy, and attribute graft failure …
The significance of mixed chimaerism and cell lineage chimaerism monitoring in paediatric patients post haematopoietic stem cell transplant
S Kricke, K Rao, S Adams - British Journal of Haematology, 2022 - Wiley Online Library
Haematopoietic stem cell transplants (HSCTs) are carried out across the world to treat
haematological and immunological diseases which would otherwise prove fatal. Certain …
haematological and immunological diseases which would otherwise prove fatal. Certain …
The mandible ameliorates facial allograft rejection and is associated with the development of regulatory T cells and mixed chimerism
D De Paz, AE Aviña, E Cardona, CM Lee… - International Journal of …, 2021 - mdpi.com
Vascularized composite allografts contain various tissue components and possess relative
antigenicity, eliciting different degrees of alloimmune responses. To investigate the …
antigenicity, eliciting different degrees of alloimmune responses. To investigate the …
[HTML][HTML] Densitometry of STR-PAGE for donor chimerism in acute leukemia's: A simple method for routine use
A Nayyar, S Ahmed - Pakistan Journal of Medical Sciences, 2024 - ncbi.nlm.nih.gov
Objective: To evaluate a PCR based method of polyacrylamide gel electrophoresis of short
tandem repeats and its quantification for detecting donor chimerism after haematopoietic …
tandem repeats and its quantification for detecting donor chimerism after haematopoietic …
Is mixed chimerism post allogeneic hematopoietic stem cell transplantation in pediatric acute lymphoid leukemia a prognostic factor for relapse?
S Khan, Z AlSaif, K Siddiqui, H AlSaedi… - … /Oncology and Stem Cell …, 2023 - hosct.org
Abstract Hematopoietic Stem Cell Transplantation (HSCT) has been considered curative for
children with high-risk acute leukemia (ALL) offering better survival. Short tandem repeat …
children with high-risk acute leukemia (ALL) offering better survival. Short tandem repeat …
DNA methylation of hematopoietic stem/progenitor cells from donor peripheral blood to patient bone marrow: implications for allogeneic hematopoietic stem cell …
I Laurenzana, L De Luca, P Zoppoli, G Calice… - Clinical and …, 2023 - Springer
Allogeneic hematopoietic stem cell transplantation (AHSCT) is a life-saving treatment for
selected hematological malignancies. So far, it remains unclear whether transplanted …
selected hematological malignancies. So far, it remains unclear whether transplanted …
MỐI LIÊN QUAN GIỮA KẾT QUẢ CHIMERISM VÀ MỘT SỐ BIẾN CHỨNG SAU GHÉP TẾ BÀO GỐC ĐỒNG LOÀI ĐIỀU TRỊ MỘT SỐ BỆNH MÁU TẠI VIỆN HUYẾT …
BQ Khánh, NB Khanh, VTT Bình… - Tạp chí Y học Việt …, 2024 - tapchiyhocvietnam.vn
Tóm tắt Đánh giá chuyển đổi mảnh ghép giữa người hiến-bệnh nhân (chimerism) có ý
nghĩa quan trọng trong theo dõi kết quả ghép. Mục tiêu: Tìm hiểu mối liên quan giữa kết quả …
nghĩa quan trọng trong theo dõi kết quả ghép. Mục tiêu: Tìm hiểu mối liên quan giữa kết quả …
Relationship between Molecular Chimerism and Graft Versus Host Disease after Allogenic Hematopoietic Stem Cell Transplantation
S Etemad, H Ayatollahi, M Salehi, P Siyadat… - Iranian Journal of …, 2020 - ijpho.ssu.ac.ir
Background: Bone marrow transplantation (BMT) is considered as a curative therapy for a
broad range of diseases. However, complications such as relapse and graft versus host …
broad range of diseases. However, complications such as relapse and graft versus host …
急性骨髄性白血病や骨髄異形成症候群において同種移植後の循環腫瘍DNA 残存は再発を予測するバイオマーカーである
横山和明 - 臨床血液, 2021 - jstage.jst.go.jp
抄録 循環腫瘍 DNA (ctDNA) は迅速かつ非侵襲的なバイオマーカーとして注目されているが,
急性骨髄性白血病や骨髄異形成症候群 (AML/MDS) において, 特に微小残存病変における …
急性骨髄性白血病や骨髄異形成症候群 (AML/MDS) において, 特に微小残存病変における …